echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > [hot spot] Jilin Province officially implemented on July 16! 133 blood products, 54 insulin drugs limited price hanging net (with drug catalog attached)

    [hot spot] Jilin Province officially implemented on July 16! 133 blood products, 54 insulin drugs limited price hanging net (with drug catalog attached)

    • Last Update: 2018-07-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    133 blood products and 54 insulin drugs will implement the price limit hanging network Jilin Public Resource Trading Center will publicize the review results and price limit of the submitted price source and supply guarantee products on July 3, 2018 Among them, 137 blood products and 55 insulin drugs have passed the examination It is indicated in the document that the publicity period is 7 days In this period, if there is any objection to the result of qualification review and price limit of the enterprise, or if there is any objection to the result of qualification review and price limit of other enterprises, corresponding coordination can be carried out Now that the publicity period has passed, Jilin Public Resources Trading Center has issued a notice on the publication and implementation of the list of blood products and insulin drugs on price limit The notice clearly points out that the published blood products and insulin drugs have been officially reviewed and will be implemented on July 16, 2018 According to the final list of price limiting drugs, 133 blood products and 54 insulin drugs have passed the examination That is to say, four (Note: here refers to the product specification) blood products are out of the market, namely: human albumin injection produced by Shanghai Laishi blood products Co., Ltd (specification: 10g / bottle (20%), 50ml), HBIG produced by Nanyue biopharmaceutical Co., Ltd (specification: Anti hbs200iu (2ml) per bottle), HBIG produced by Nanyue biopharmaceutical Co., Ltd (specification: Anti hbs100iu (1ml) per bottle), HBIG injection produced by Tonglu biopharmaceutical Co., Ltd (specification: 200iu / bottle) However, there is only one insulin drug out of the market, which is adenosine triphosphate coenzyme insulin for injection (actual specification: adenosine triphosphate disodium 20mg, coenzyme A50 unit, insulin 4 unit) In addition to the above information, the publicity also gives these specific requirements The negotiation price between medical institutions and enterprises shall not be higher than the price limit this time Each medical institution shall select its own purchase catalogue according to the clinical drug demand, carry out negotiation with the corresponding enterprises and determine the purchase price The purchase price negotiated and determined by the medical institution and the enterprise shall not be higher than the limit price, and shall not be higher than the current purchase price of the unit The medical institution shall enter the determined negotiation and purchase price into the platform, and carry out purchase transactions through the platform It is forbidden to purchase under the network or outside the directory All medical institutions shall hang the online directory according to the limited price, and purchase relevant drugs through the pharmaceutical equipment purchase service platform of the provincial public resources trading center in combination with the actual use of the unit It is forbidden to purchase under the network or outside the directory Medical institutions at all levels shall sign drug purchase and sale contracts and honest purchase and sale contracts, and strictly implement the "two ticket system" for drug purchase The enterprise shall purchase according to law, and the administrative organ shall strictly check the supervision publicity to show that the health and family planning administrative departments and medical institutions at all levels shall attach great importance to it, establish and improve the supervision and management mechanism in accordance with the principle of "localized management", strengthen leadership, set up special personnel, clarify responsibilities, and do a good job in organizing and implementing the network results At the same time, the administrative departments of health and family planning at all levels should strengthen their management functions, strengthen supervision, and strictly investigate and punish the behaviors of avoiding centralized drug purchase, offline and beyond the scope of purchase, and not collecting money on time Attachment: Jilin blood products and insulin drugs limited price online catalog content source: Jilin Public Resources Trading Center
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.